EUROMEDICA 

Hanover

6-7  Juni 2008

Advanced methods of diagnosis,
treatment and prophylactics

European Academy of Natural Sciences, Hanover

European Scientific Society, Hanover

Russian Academy of Natural Sciences, Moscow


I. Plotnikova
I. Trushkina
T. Suslova
G. Filippov
METABOLIC PROFILE OF ADOLESCENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
Research Institute of cardiology, Tomsk, Russia

The clinical diagnosis of dysmetabolic syndrome in adolescents accelerates the risk for cardiovascular events. These risk factors are being expressed at young ages. In this study, we determine the prevalence of the components of metabolic syndrome among adolescents aged 12-18 years from West Siberia. Data were analyzed for 326 adolescents (70% males), mean age 14,9 ±2,2 years, who had an increased blood pressure. The metabolic syndrome is defined as a constellation of laboratory and physical findings such as raised triglyceride (≥1.13 mmol/l), reduced high-density lipoprotein-cholesterol (≤1.04 mmol/l ), raised blood pressure ( ≥90th percentile) and raised fasting plasma glucose (≥6.1 mmol/l). Prevalence of the metabolic syndrome was estimated according to the National Cholesterol Education Program Adult Treatment Panel III, using NHANES III data. The control group consisted of 27 healthy adolescents. As the components of the syndrome, frequency were as follows: 6,4% for abdominal obesity, 22,3% for elevated triglyceride, 34,7% for reduced high-density lipoprotein-cholesterol, based upon daily AP monitoring 40% with labile form of arterial hypertension and 30% with stabile form and 30% with «white-coat» hypertension. Most of the hypertensive teens had hyperuricemia (74%), some of the patients combined hyperuricemia with changes in glycemic profile of blood (14%). Metabolic syndrome mono-markers were revealed in 66.6% of adolescents having the phenomenon of “white coat hypertension” and in 78.3% of those with labile hypertension. Only 7.4% of adolescents with essential hypertension had no diagnosis signs of metabolic syndrome. Thus early diagnosis and treatment of metabolic syndrome just in the stage of metabolic disturbances development will allow to prevent such diseases as arterial hypertension, coronary artery disease, diabetes mellitus of the 2-nd type.